Knight Therapeutics | GUD - Cost Of Sales



Knight Therapeutics reported CAD47.25M in Cost of Sales for its fiscal quarter ending in September of 2024.


Cost Of Sales Change Date
Alaunos Therapeutics 0 18K Sep/2024
Aurora Cannabis CAD 70.07M 8.78M Jun/2025
Avita Medical AUD 2.28M 170K Dec/2024
Canopy Growth CAD 54.1M 3.44M Jun/2025
Cronos Group USD 19.65M 1.12M Jun/2025
Ionis Pharmaceuticals USD 4.15M 3.15M Jun/2025
IQVIA Holdings USD 2.97B 439M Jun/2025
Knight Therapeutics CAD 47.25M 990K Sep/2024
Moderna USD 119M 29M Jun/2025
Organigram Holdings CAD 44.65M 2.96M Jun/2025
Organon & Co USD 720M 48M Jun/2025
Revvity USD 327.73M 38.51M Jun/2025
Tilray USD 149.73M 9.39M Nov/2024
Viatris USD 2.25B 229.7M Jun/2025
Xeris Pharmaceuticals USD 11.9M 2.42M Jun/2025